Daftar ini adalah analisis berdasarkan peristiwa pasar terbaru. Ini bukan rekomendasi investasi.
Tentang
Sourcebio International Plc, together with its subsidiaries, provides various laboratory services and products to clients in the healthcare, clinical, life science research, and biopharma industries in the United Kingdom, Europe, the United States, and internationally. The company's services cover histopathology cancer screening and clinical diagnostic services; DNA sequencing services and precision medicine to pharmaceutical and biotechnology companies, academia, contract research organizations, and other research markets; shelf-life testing services and equipment; and COVID-19 antigen PCR testing services. It also manufactures library clones, direct to consumer home test kits, and blood and tissue serological products; and provides employee testing solutions and venue testing. In addition, the company offers controlled environment storage services and diagnostic and genomic services and products. Sourcebio International Plc was founded in 1999 and is headquartered in Nottingham, the United Kingdom.
Tergantung pada bursa, simbol saham dapat berbeda. Misalnya, di bursa Boerse Stuttgart, saham SourceBio International diperdagangkan dengan simbol 6J8.STU.
Berapa jumlah karyawan SourceBio International?▼
Per 2 November 2026, perusahaan memiliki 339 karyawan.
SourceBio International berada di sektor apa?▼
SourceBio International beroperasi di sektor Kesehatan & Kebugaran.
Kapan SourceBio International menyelesaikan split saham?▼
SourceBio International belum melakukan split saham baru-baru ini.
Di mana kantor pusat SourceBio International?▼
Kantor pusat SourceBio International berlokasi di Nottingham, Britania Raya.